| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 23, 2013 | Alpha Street Research | Hunter Orr | ABT - Abbott Laboratories - Upgraded to a Buy - Company Analysis and ASR Ranking Report | 9 | $24 | | May 22, 2013 | Thomson Reuters Stock Report | StockReports + Research Department | Thomson Reuters Stock Report - ABBOTT LABORATORIES (ABT-N) | 12 | $25 | | May 22, 2013 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for ABT | 11 | $126.50 | | May 22, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Large CAP Pharma | 17 | $195.50 | | May 22, 2013 | Stock Traders Daily | Thomas H Kee Jr. | Trading Report for (ABT). A detailed report, including free correlated market analysis, and updates. | 5 | $57.50 | | May 20, 2013 | Directors Deals Ltd. | Company Snapshot | Company Snapshot - Abbott Laboratories | 1 | $11.50 | | May 20, 2013 | Stock Traders Daily | Thomas H Kee Jr. | The Investment Rate - a measure of investment demand. | 43 | $494.50 | | May 19, 2013 | Pechala's Reports | Lubomir Pechala | ABBOTT LABORATORIES (ABT) - REPORT FOR ACTIVE TRADERS | 1 | $25 | | May 19, 2013 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | | May 17, 2013 | S&P Capital IQ – STARS Reports | N/A | Abbott Laboratories | 10 | $115 |
|
View All Reports for ABT ... |
|
|
0.25(0.66%) 2:32PM EDT - Nasdaq Real Time Price